Twelve-Month Metabolic Declines in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment Assessed Using an Empirically Pre-Defined Statistical Region-of-Interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

Alzheimer's disease (AD) is characterized by specific and progressive reductions in fluorodeoxyglucose positron emission tomography (FDG PET) measurements of the cerebral metabolic rate for glucose (CMRgl), some of which may precede the onset of symptoms. In this report, we describe twelve-mont...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen, Kewei, Langbaum, Jessica B.S., Fleisher, Adam S., Ayutyanont, Napatkamon, Reschke, Cole, Lee, Wendy, Liu, Xiaofen, Bandy, Dan, Alexander, Gene E., Thompson, Paul M., Foster, Norman L., Harvey, Danielle J., de Leon, Mony J., Koeppe, Robert A., Jagust, William J., Weiner, Michael W., Reiman, Eric M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856742/
https://ncbi.nlm.nih.gov/pubmed/20202480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroimage.2010.02.064
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares